Thyrotropin-Releasing Hormone Receptor Type 1 (TRH-R1), not TRH-R2, Primarily Mediates Taltirelin Actions in the CNS of Mice
- 11 December 2012
- journal article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 38 (6) , 950-956
Abstract
Thyrotropin-releasing hormone receptor type 2 (TRH-R2), not TRH-R1, has been proposed to mediate the CNS effects of TRH and its more effective analog taltirelin (TAL). Consistent with this idea, TAL exhibited higher binding affinity and signaling potency at mouse TRH-R2 than TRH-R1 in a model cell system. We used TRH-R1 knockout (R1ko), R2ko and R1/R2ko mice to determine which receptor mediates the CNS effects of TAL. There was no TRH-R1 mRNA in R1ko and R1/R2ko mice and no TRH-R2 mRNA in R2ko and R1/R2ko mice. Specific [3H]MeTRH binding to whole brain membranes was 5% of wild type (WT) for R1ko mice, 100% for R2ko mice and 0% for R1/R2ko mice, indicating TRH-R1 is the predominant receptor expressed in the brain. In arousal assays, TAL shortened sleep time with pentobarbital sedation in WT and R2ko mice by 44 and 49% and with ketamine/xylazine sedation by 66 and 55%, but had no effect in R1ko and R1/R2ko mice. In a tail flick assay of nociception, TAL increased response latency by 65 and 70% in WT and R2ko mice, but had no effect in R1ko and R1/R2ko mice. In a tail suspension test of depression-like behavior, TAL increased mobility time by 49 and 37% in WT and R2ko mice, but had no effect in R1ko and R1/R2ko mice. Thus, in contrast to the generally accepted view that the CNS effects of TAL are mediated by TRH-R2, these effects are mediated primarily if not exclusively by TRH-R1 in mice.Keywords
This publication has 27 references indexed in Scilit:
- Taltirelin is a superagonist at the human thyrotropin-releasing hormone receptorFrontiers in Endocrinology, 2012
- TRH-Receptor-Type-2-Deficient Mice are Euthyroid and Exhibit Increased Depression and Reduced Anxiety PhenotypesNeuropsychopharmacology, 2008
- A Virtual Screen for Diverse Ligands: Discovery of Selective G Protein-Coupled Receptor AntagonistsJournal of the American Chemical Society, 2008
- A novel TRH analog, Glp–Asn–Pro–d-Tyr–d-TrpNH2, binds to [3H][3-Me-His2]TRH-labelled sites in rat hippocampus and cortex but not pituitary or heterologous cells expressing TRHR1 or TRHR2Neuroscience Letters, 2008
- Thyrotropin-releasing hormone (TRH) in the neuroaxis: Therapeutic effects reflect physiological functions and molecular actionsMedical Hypotheses, 2007
- Models of Nociception: Hot‐Plate, Tail‐Flick, and Formalin Tests in RodentsCurrent Protocols in Neuroscience, 2007
- The Thyrotropin-Releasing Hormone (TRH) Hypothesis of Homeostatic Regulation: Implications for TRH-Based TherapeuticsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- TRH-R2 Exhibits Similar Binding and Acute Signaling but Distinct Regulation and Anatomic Distribution Compared with TRH-R1Molecular Endocrinology, 2000
- Taltirelin Hydrate (TA‐0910): An Orally Active Thyrotropin‐Releasing Hormone Mimetic Agent with Multiple ActionsCNS Drug Reviews, 1998
- Mechanism of Thyrotropin Releasing Hormone Stimulation of Pituitary Hormone SecretionAnnual Review of Physiology, 1986